packageLonafarnib

lonafarnib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lonafarnib is a farnesyltransferase enzyme inhibitor used to treat progeria and certain laminopathies. It is an approved medicine, authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q3258910 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lonafarnib
ATC codes:A16AX20
DrugBank:DB06448
PubChem CID:148195
ChEBI:47097
Wikidata:Q3258910
formula:C27H31Br2ClN4O2
molar mass:638.829 g/mol (PubChem CID 148195)
logP:4.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown